Komen Foundation Announces Application Deadline For 1999 National Grants

February 24, 1999

DALLAS - Feb. 19, 1999 -- The Susan G. Komen Breast Cancer Foundation, credited as the nation's leading catalyst in the fight against breast cancer, today announced that all national grant applications are due by April 1, 1999. For 17 years, the Komen Foundation's National Grant Program has been a pioneer in the funding of groundbreaking breast cancer research, and today, it is regarded as the most innovative and responsive grant program in breast cancer.

Applications and instructions for 1999 national grants from the Komen Foundation are available to download from the Foundation's Web site, www.komen.org/grants/. Applications can also be obtained by calling the Komen Foundation Grants Department toll free at 888-300-5582.

Grants are available in the following categories:
Basic, Clinical and Translational Breast Cancer Research: This program is intended to foster investigations into the cause, treatment, prevention and cure of breast cancers. Particular emphasis will be given to projects that are innovative, non-duplicative of other efforts and have the potential to lay the groundwork for continuing study. The program offers grants of up to $250,000 over a two-year period.

Dissertation Research Award: Funding is available for doctoral candidates in the fields of health and social sciences to conduct dissertation research on breast health and breast cancer. Particular emphasis will be given to projects offering an indication of the potential to help the Foundation meet its mission to eradicate breast cancer as a life-threatening disease. The program offers funding between $20,000 and $30,000 over a two-year period. Applications must be submitted by the dissertation supervisor.

Imaging Technology: This new grant program, which is made possible through matching funds from the Joseph Drown Foundation, was created to fund research and develop methods for early detection and diagnosis of breast cancer. Particular emphasis will be given to projects that are innovative and non-duplicative of other efforts. The program offers funding of $125,000 annually for two years.

Population-Specific Research Projects: Funding is available for innovative projects addressing breast cancer epidemiology within specific populations at risk for the disease. The focus of the program is to identify unique needs, trends and barriers to breast health care among populations such as African American, Asian/Pacific Islander, Hispanic, Native American, Lesbian, Low Literacy and other defined communities. Particular emphasis will be given to projects that are innovative, non-duplicative of other efforts and have the potential to serve as models for national implementation. The program offers funding of up to $75,000 annually for a two-year period.

Postdoctoral Fellowship in Breast Cancer Research, Public Health or Epidemiology: Grants will be given to fund postdoctoral fellowships in the areas of breast cancer research, public health or epidemiology. The program is intended to encourage young scientists to begin a career in breast cancer research or to support continued independent investigations in breast health and breast cancer. Particular emphasis will be given to projects that are innovative, non-duplicative of other efforts and have the potential to lay the groundwork for continuing study. The program offers funding of $35,000 annually for three years. Applicants must be sponsored by a principal investigator from the same institution.

1999 Brinker International Awards for Breast Cancer Research: Two awards will be given to honor outstanding individuals for their achievement in the field of breast cancer: one in basic science and one in clinical medicine. The awards will recognize outstanding work that has advanced basic research concepts or affected clinical applications in the field of breast cancer research, screening or treatment. The intent is to recognize scholars for a specific contribution, a consistent pattern of contributions or leadership in the field that has had a substantial impact on breast cancer. Each award includes a $10,000 honorarium, a citation and an inscribed, limited-edition crystal statuette designed by Tiffany & Co.

Credited as the nation's leading catalyst in the fight against breast cancer, the Susan G. Komen Breast Cancer Foundation and its powerful network of volunteers continue to lead the fight against the disease. Established in 1982 by Nancy Brinker to honor the memory of her sister, Susan G. Komen, who died from breast cancer at age 36, the Komen Foundation's mission is to eradicate breast cancer as a life-threatening disease by advancing research, education, screening, and treatment. The Komen Foundation is one of the nation's largest private providers of funds for breast cancer research, awarding more than $11 million in grants in 1998.
For more information on the Komen Foundation's National Grant Program, call 1-888-300-5582 or visit the Foundation's Web site at www.komen.org. E-mail inquiries may be addressed to grants@komen.org.

The Susan G. Komen Breast Cancer Foundation

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.